Skip to main content
logo
Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
6.03
+0.03 (0.50%)
Aug 4, 2026, 12:43 PM EDT - Market open

ARCT Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
54.7182.03152.31166.820612.36
Revenue Growth
-61.92%-46.14%-8.69%-19.03%1566.79%29.56%
Gross Profit
54.7182.03152.31166.820612.36
Selling, General & Admin
44.2346.0852.8252.8746.0741.45
Research & Development
98.85112.21195.16192.13147.75173.76
Total Operating Expenses
143.08158.29247.98245193.82215.21
Operating Income
-88.37-76.26-95.67-78.2112.18-202.85
Total Non-Operating Income (Expense)
9.2910.4814.7250.32-1.53-0.82
Pretax Income
-79.08-65.78-80.95-27.8910.64-203.67
Provision for Income Taxes
---01.841.3-
Net Income
-78.67-65.78-80.94-29.739.35-203.67
Net Income to Common
-78.67-65.78-80.94-29.739.35-203.67
Net Income Growth
------
Shares Outstanding (Basic)
282727272626
Shares Outstanding (Diluted)
282727272726
Shares Change
2.51%1.43%1.40%-1.72%2.95%11.82%
EPS (Basic)
-2.81-2.40-3.00-1.120.35-7.74
EPS (Diluted)
-2.81-2.40-3.00-1.120.35-7.74
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-58.67-74.5-60.4-2124.27-138.45
Free Cash Flow Growth
------
Free Cash Flow Per Share
-2.12-2.72-2.24-0.790.90-5.26
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-161.52%-92.96%-62.81%-46.89%5.91%-1641.33%
Profit Margin
-143.80%-80.19%-53.14%-17.82%4.54%-1647.98%
FCF Margin
-107.23%-90.82%-39.65%-12.59%11.78%-1120.23%
EBITDA
-85.48-73.24-92.13-75.2513.7-201.66
EBITDA Margin
-156.25%-89.28%-60.49%-45.11%6.65%-1631.68%
EBIT
-88.37-76.26-95.67-78.2112.18-202.85
EBIT Margin
-161.52%-92.96%-62.81%-46.89%5.91%-1641.33%
Effective Tax Rate
-0.00%0.00%-6.58%12.17%0.00%
SEC Filings: 10-K · 10-Q